Chat with GenHealth to automate any coding or chart task.
Name of the Condition
- Tributary (branch) retinal vein occlusion, bilateral, with retinal neovascularization (ICD-10-CM: H34.8331)
Summary
Tributary (branch) retinal vein occlusion, bilateral, with retinal neovascularization is a condition where blockages occur in the smaller branches of the retinal vein system in both eyes, leading to abnormal new blood vessel growth (neovascularization) on the retina. This disrupts blood flow from portions of the retina in each eye, potentially causing vision changes such as blurring or distortion. The bilateral involvement and presence of neovascularization distinguish this condition from unilateral or non-neovascular forms, often requiring targeted management to preserve visual function and prevent complications.
Causes
The condition is typically caused by blood clots or thrombi forming in tributary retinal veins. Underlying factors such as atherosclerosis, inflammation, or vein compression may contribute to the blockage. Systemic conditions like hypertension or hypercoagulability can also play a role in its development. The retinal neovascularization arises from ischemia (lack of blood flow) due to the occlusion, triggering abnormal vessel growth as a response to reduced oxygen supply.
Risk Factors
- Advanced age
- Hypertension
- Diabetes mellitus
- High cholesterol
- Smoking
- Cardiovascular disease
- Glaucoma
- Blood disorders (e.g., hypercoagulability)
Symptoms
- Blurred or distorted vision in both eyes
- Floaters or dark spots in the visual field
- Peripheral vision loss in affected areas
- Sudden or gradual onset of vision changes
- Potential for bleeding from new blood vessels (neovascularization)
Diagnosis
Diagnosis involves a comprehensive eye examination, including visual acuity testing, dilated funduscopy, and imaging studies like optical coherence tomography (OCT) or fluorescein angiography. These tests help assess the extent of the occlusion, identify neovascularization, and evaluate retinal ischemia. Visual field testing may also be used to detect peripheral vision loss.
Treatment Options
Treatment focuses on managing the underlying occlusion and neovascularization. Options may include anti-VEGF injections to reduce abnormal blood vessel growth, laser photocoagulation to treat ischemic areas, and addressing systemic risk factors (e.g., controlling blood pressure or diabetes). Regular monitoring is essential to detect and manage complications.
Prognosis and Follow-Up
Prognosis depends on the severity of the occlusion and neovascularization. Early intervention can help preserve vision, but bilateral involvement may increase the risk of permanent vision loss. Follow-up care typically includes regular eye examinations to monitor for neovascularization progression, retinal changes, or complications like macular edema or hemorrhage.
Complications
- Retinal hemorrhage
- Macular edema
- Vision loss
- Glaucoma (due to neovascularization)
- Retinal detachment
Lifestyle & Prevention
- Manage systemic conditions (e.g., hypertension, diabetes)
- Quit smoking
- Maintain a healthy diet and exercise routine
- Regular eye examinations for early detection
When to Seek Professional Help
Seek immediate medical attention if you experience sudden vision changes, increased floaters, or eye pain, as these may indicate worsening neovascularization or complications.
Tips for Medical Coders
Document the bilateral nature of the tributary retinal vein occlusion and the presence of retinal neovascularization clearly. Ensure clinical notes specify the involvement of both eyes and the neovascularization to support accurate coding.
H34.8331 policy automation walkthrough
Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.